Search - Université de Rennes Access content directly

Filter your results

18 Results
Structure: Internal structure identifier : 142307

Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.

Anne-Sophie Moreau , Yasmine Sebti , Alain Duhamel , Aldo M. Roccaro , Valérie Coiteux et al.
European Journal of Haematology, 2008, 80 (6), pp.503-9. ⟨10.1111/j.1600-0609.2008.01060.x⟩
Journal articles istex hal-00675965v1
Image document

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

Hermann Einsele , Javier Briones , Fabio Ciceri , Irene García-Cadenas , Fred Falkenburg et al.
HemaSphere, 2020, 4 (4), pp.e423. ⟨10.1097/HS9.0000000000000423⟩
Journal articles hal-03012806v1
Image document

Total immunotherapy for Hodgkin lymphoma

Roch Houot , Reid W. Merryman , Franck Morschhauser
Lancet Haematology, 2020, 7 (9), pp.e629-e630. ⟨10.1016/S2352-3026(20)30220-9⟩
Journal articles hal-02930371v1

Immune and Cell Therapy in Non-Hodgkin Lymphoma

Reid W. Merryman , Roch Houot , Philippe Armand , Caron Jacobson
Cancer Journal, 2020, 26 (3), pp.269-277. ⟨10.1097/PPO.0000000000000445⟩
Journal articles hal-02890214v1
Image document

Cross-species analysis of enhancer logic using deep learning

Liesbeth Minnoye , Ibrahim Ihsan Taskiran , David Mauduit , Maurizio Fazio , Linde van Aerschot et al.
Genome Research, 2020, 30 (12), pp.1815-1834. ⟨10.1101/gr.260844.120⟩
Journal articles hal-02961183v1
Image document

Evidence for transcript networks composed of chimeric RNAs in human cells

Sarah Djebali , Julien Lagarde , Philipp Kapranov , Vincent Lacroix , Christelle Borel et al.
PLoS ONE, 2012, 7 (1), Non paginé. ⟨10.1371/journal.pone.0028213⟩
Journal articles hal-01216248v2

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Roch Houot , Tony Marchand , Nathalie Dhédin , Willy Lescaut , Anne Thiebaut-Bertrand et al.
Blood, 2017, 129 (10), pp.1380-1388. ⟨10.1182/blood-2016-09-738385⟩
Journal articles hal-01517054v1

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Bijal Shah , Armin Ghobadi , Olalekan Oluwole , Aaron Logan , Nicolas Boissel et al.
Journal of Hematology and Oncology, 2022, 15 (1), pp.170. ⟨10.1186/s13045-022-01379-0⟩
Journal articles hal-04069449v1

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal D Shah , Armin Ghobadi , Olalekan O Oluwole , Aaron C Logan , Nicolas Boissel et al.
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
Journal articles hal-03260932v1

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly , Jaffer A. Ajani , Jaroslaw Kuzdzal , Thomas Zander , Eric van Cutsem et al.
New England Journal of Medicine, 2021, 384 (13), pp.1191-1203. ⟨10.1056/NEJMoa2032125⟩
Journal articles hal-03217222v1

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Reid Merryman , Luca Castagna , Laura Giordano , Vincent Ho , Paolo Corradini et al.
Leukemia, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
Journal articles hal-03229516v1
Image document

Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Aiping Chen , Fatima-Zohra Mokrane , Lawrence Schwartz , Franck Morschhauser , Apasia Stamatoullas et al.
Journal of Nuclear Medicine, 2020, 61 (5), pp.649-654. ⟨10.2967/jnumed.119.232827⟩
Journal articles hal-02364994v1
Image document

Cretaceous African life captured in amber

A. Schmidt , V. Perrichot , M. Svojtka , K. Anderson , H. Belete et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (16), pp.7329 - 7334. ⟨10.1073/pnas.1000948107⟩
Journal articles insu-00600295v1

Chimeric antigen receptor (CAR) T-cells on the march from diffuse large B-cell lymphoma to mantle cell lymphoma

Roch Houot , Philippe Armand , Caron A Jacobson
European Journal of Cancer, 2020, 131, pp.51-52. ⟨10.1016/j.ejca.2020.03.001⟩
Journal articles hal-02569416v1

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas

Ajay K Gopal , Ronald Levy , Roch Houot , Sandip P Patel , Leslie Popplewell et al.
Clinical Cancer Research, 2020, 26 (11), pp.2524-2534. ⟨10.1158/1078-0432.CCR-19-2973⟩
Journal articles hal-02563360v1
Image document

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma

John Timmerman , Charles Herbaux , Vincent Ribrag , Andrew D. Zelenetz , Roch Houot et al.
American Journal of Hematology, 2020, 95 (5), pp.510-520. ⟨10.1002/ajh.25757⟩
Journal articles hal-02798009v1

Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population

Samuel Vic , Jean Lemoine , Philippe Armand , François Lemonnier , Roch Houot et al.
European Journal of Cancer, 2022, 175, pp.246-253. ⟨10.1016/j.ejca.2022.08.019⟩
Journal articles hal-04098893v1
Image document

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Roch Houot , Ronald Levy , Guillaume Cartron , Philippe Armand
European Journal of Cancer, 2020, 136, pp.4-6. ⟨10.1016/j.ejca.2020.06.017⟩
Journal articles hal-02929021v1